Agostini et al., Blood, v93 (No. 4), pp. 1277-1286 (Feb. 1999). |
Ferrari-Lacraz et al., Jrl. Of Immuno., v167 (No. 6), pp. 3478-3485 (Se. 2001). |
Kim et al., Jrl. Of Immuno., v160 (No. 12), pp. 5742-5748 (Je. 1998). |
Kim et al., Transplantation Proceedings, v30 (No. 8), pp. 4031-4036 (1998). |
Lin, et al. The Role of Shared Receptor Motifs and Common Stat Proteins in the Generation of Cytokine Pleiotropy and Redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity, 2:331-339 (Apr. 1995). |
Morrison, et al. Structural Determinants of Human IgG Function. The Immunologist 2(4):119-124 (1994). |
Brekke, et al. Structure-Function Relationships of Human IgG. The Immunologist 2(4):125-130 (1994). |
Pettit, et al. Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling. The Journal of Biological Chemistry 272(4): 2312-2318 (1997). |
Stevens, et al. Interleukin-15 signal, T84 colonic epithelial cells in the absence of the interleukin-2 receptor β-chain. Am. J. Physiol. 272:G1-G8 (1997). |
Armitage, et al. IL-15 Has Stimulatory Activity for the Induction of B Cell Proliferation and Differentiation. Journal of Immunology 154:483-490 (1995). |
Chae, et al. Distribution of IL-15 Receptor α-Chains on Human Peripheral Blood Mononuclear Cells and Effect of Immunosuppressive Drugs on Receptor Expression. Journal of Immunology 157:2813-2819 (1996). |
Moreland, et al. Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein. N. Engl. J. Med 337(3):141-147 (1997). |
Elliott, et al. Repeated therapy with monoclonal antibody to tumor necrosis factor a (cA2) in patients with rheumatoid arthritis. Lancet 344(8930):1125-1127 (1994). |
Elliott, et al. Randomized double-blind comparison of cheneric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344(8930):1105-1110 (1994). |
Williams, et al. Successful therapy of collagen-induced arthritis with TNF receptor-IFG fusion protein and combination with anti-CD4. Immunology 84(3): 433-439 (1995). |
Wooley, et al. Influence of a Recombinant Human Soluble Tumor Necrosis Factor Receptor FC Fusion Protein on Type II Collagen-Induced Arthristis in Mice. Journal of Immunology 151(11):6442-6607 (1993). |
Vey, et al. IFN-γ and I,25 (OH) 2D3 Induce on THP-1 Cells Distinct Patterns of Cell Surface Antigen Expression, Cytokine Production, and Responsiveness to Contact with Activated T Cells. Journal of Immunology 149(6):2040-2046 (1992). |
Courtenay, et al. Immunisation against heterologous type II collagen induces arthristis in mice. Nature 283(5748): 666-668 (1980). |
Burger, et al. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases I in synociocytes and fibroblasts upon direct contact with stimulated T Lymphocytes. Arthristis & Rheumatism 41(10):1748-1759 (1998). |
Kim, et al. Targeting the IL-15 Receptor with an Antagonist IL-15 Mutant/Fcy2a Protein Blocks Delayed-Type Hypersensitivity. Journal of Immunology 160:5742-5748 (1998). |
Li, et al. Induction of Allograft Tolerance in the Absence of Fas-Mediated Apoptosis. Journal of Immunology 163:2500-2507 (1999). |
Kim, et al. Targeting the IL-15 Receptor with an Antagonist IL-15/Fcγ2a Protein BlocksDTH and Enhances the Acceptance of Islet Allografts. 7th ASTP (Physicist) Annual Meeting, Chicago, IL May 9-13, 1998 (p. 713). |
Kirk, et al. Treatment of humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Medicine 5(6):686-693 (1999). |
Nickerson, et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transplant Immunology 4:81-85 (1996). |
Lakkis, et al. Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosupressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein. Eur. J. Immunol. 21:2253-2258 (1991). |
Li, et al. Blocking both signal 1 and signal 2 of T-cell Activation prevent apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Medicine 5(11):1298-1302 (1999). |